Julija Hmeljak PhD

Scientific Editor, The Company of Biologists

Julija completed her PhD in Basic Medical Sciences at the University in Ljubljana, Slovenia. In 2013, she joined Marc Ladanyi’s group at Memorial Sloan Kettering Cancer Center in New York, where she continued her work on the molecular mechanisms of mesothelioma and rare pediatric sarcomas. She joined the editorial team of Disease Models & Mechanisms, a The Company of Biologists journal, in 2017, where she is responsible for commissioned front-section content.